Acute & Interventional Cardiology 2004; Volume 11: pages AIC 1- AIC 104

Recombinant factor VIIa (rFVIIa, Novoseven®, Novo Nordisk®, Denmark) is established for the management of bleeding episodes in haemophiliac patients with inhibitors. Interest has been growing...

There are many advantages to bioabsorbable stents, including the potential to inhibit intimal hyperplasia by avoiding prolonged foreign body reaction and/or releasing antiproliferative drugs during...

Bivalirudin is a direct thrombin inhibitor that will be available in the UK in November 2004 as adjunctive anticoagulant therapy during percutaneous coronary intervention (PCI)....

This study was set up to investigate the prognostic significance of different bands of troponin T in the diagnosis and management of patients presenting with...

We report a case of unprotected, ostial left main coronary artery disease successfully treated with a rapamycin-coated ‘Cypher’ stent in an 81-year-old woman who was...

The benefits of transradial coronary intervention (TRI) over transfemoral (TFI) are becoming increasingly recognised. In the United Kingdom, an increasing number of interventions are being...

The success of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) in ameliorating atherothrombotic events is firmly established. Large randomised controlled clinical trials have consistently (and unequivocally)...

The use of coronary angiography as a diagnostic tool in modern hospital medicine continues to rise. With the increasing use of therapeutic coronary interventions, and...

The pulmonary artery catheter (PAC) was introduced into critical care medicine without objective evidence of its efficacy. The direct risks from the PAC are around...

Isolated ventricular non-compaction is a rare cardiomyopathy, which is probably underdiagnosed. We describe a case manifested by chest pain, indistinguishable from acute myocardial...

Ventricular tachycardia (VT) and sudden cardiac death are feared complications of severe heart failure, whatever the aetiology. VT has the propensity to become incessant, and...

Primary cardiac lymphomas (PCL) are rare neoplasms. They occur at any age and are rare in immunocompetent patients, accounting for 1.3% of all cardiac tumours...

Heart failure is an increasingly common condition for which device therapy, including the advanced pacing technique cardiac resynchronisation therapy, is becoming an accepted treatment. In...

Despite the availability of an array of medical therapies for the treatment of heart failure, quality of life is often poor for the majority of...

The measurement of biochemical markers of myocardial cell damage is a key component of modern cardiology practice. The use of these tests in the diagnosis...

In this issue of Acute and Interventional Cardiology there is a commissioned editorial about the release of cardiac enzymes after percutaneous coronary intervention (PCI). This...

Percutaneous treatment of bifurcation coronary lesions is less successful than treatment of non-bifurcation lesions, with a higher incidence of side branch occlusion and restenosis. The...